On 25 November 2025, Novartis Pharmaceuticals conducted a study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with ...
While striations are most prominent in skeletal muscle, they are also present in cardiac muscle, the muscle that makes up the ...
Researchers uncover a synaptic-like role for macrophages in delivering calcium to muscle fibers, rapidly accelerating tissue ...
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular ...
Learn how many pushups adults over 45 need to hit top tier upper body strength, plus elite benchmarks for men and women.
U.S. Food and Drug Administration has approved Novartis' gene therapy for a type of rare muscle disorder, the drugmaker said ...
-- Muscular Dystrophy Association Calls FDA Approval of Novartis' Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community Mary Fiance, National Vice ...
A research team has found that specific immune cells can connect with muscle fibers in a lightning-fast, neuron-like way to ...
Past studies show one of the most potentially harmful areas to accumulate fat is visceral fat within the abdominal area.
The Supreme Court today asked comic Samay Raina to consider hosting a show with those suffering from Spinal Muscular Atrophy ...
Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration.
William, 16, supports Ellie, 15, who has spinal muscular atrophy, alongside his volunteer work with the Scouts, and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback